It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
In this study, published in the journal Cancer Research, the researchers used a virus called enadenotucirev, which is already in clinical trials for treating carcinomas. It has been bred to infect only cancer cells, leaving healthy cells alone.
They added genetic instructions into the virus that caused infected cancer cells to produce a protein called a bispecific T-cell engager.
The protein was designed to bind to two types of cells and stick them together. In this case, one end was targeted to bind to fibroblasts. The other end specifically stuck to T cells - a type of immune cell that is responsible for killing defective cells. This triggered the T cells to kill the attached fibroblasts.
Dr Joshua Freedman, from the Department of Oncology at the University of Oxford, who was first author on the study said: "We hijacked the virus's machinery so the T-cell engager would be made only in infected cancer cells and nowhere else in the body. The T-cell engager molecule is so powerful that it can activate immune cells inside the tumour, which are being supressed by the cancer, to attack the fibroblasts."
Dr Kerry Fisher, from the Department of Oncology at the University of Oxford, who led the research said: "Even when most of the cancer cells in a carcinoma are killed, fibroblasts can protect the residual cancer cells and help them to recover and flourish. Until now, there has not been any way to kill both cancer cells and the fibroblasts protecting them at the same time, without harming the rest of the body.
"Our new technique to simultaneously target the fibroblasts while killing cancer cells with the virus could be an important step towards reducing immune system suppression within carcinomas and should kick-start the normal immune process.
A genetically modified virus that kills cancer cells and destroys their hiding places has been developed by British scientists.
The virus, developed by Oxford University scientists, attacks carcinomas, which are the most common type of cancer. The findings were published in Cancer Research.
So researchers used a virus called enadenotucirev, which is already in clinical trials for treating carcinomas.
It has been bred to infect only cancer cells, leaving healthy cells alone.
“Until now, there has not been any way to kill both cancer cells and the fibroblasts protecting them at the same time, without harming the rest of the body.”
“Our new technique to simultaneously target the fibroblasts while killing cancer cells with the virus could be an important step towards reducing immune system suppression within carcinomas and should kick-start the normal immune process.”
Significance: An engineered oncolytic adenovirus that encodes a bispecific antibody combines direct virolysis with endogenous T-cell activation to attack stromal fibroblasts, providing a multimodal treatment strategy within a single therapeutic agent. Cancer Res; 1–14. ©2018 AACR.
originally posted by: Wide-Eyes
a reply to: rickymouse
Links please? I'm intrigued.
originally posted by: rickymouse
originally posted by: Wide-Eyes
a reply to: rickymouse
Links please? I'm intrigued.
www.insidescience.org...
trialx.com...
www.sciencedaily.com...
Cancer cells are fast replicating and they eat a lot, so the viruses are attracted to the cancer cells. You can also consume foods like parsley and celery and the hungry cancer cells gorge on the chemicals these plants contain that cause aptopsis and they die. That is the basis of one of the most recent cancer meds, you know, the one that is the highest price of all, patented celery flakes.
How about a combo of a cold and the parsley family chemistry contained within chicken soup. Double whammy against cancer. Also rutabaga has some strong anticancer properties.
originally posted by: JAGStorm
a reply to: one4all
it can be killed at the parasitic connection point
curious how, before eating or after?
originally posted by: one4all
originally posted by: strongfp
a reply to: one4all
Cancer isnt a bacteria. If it was the body would treat it as such, and a massive dose of antibiotics would treat early stages of cancer.
Its a bacteria that is pleomorphic and it adapts and adjusts.
originally posted by: rickymouse
Sounds like they found a way to genetically engineer the common cold virus so they could patent it. The common cold kills cancer cells, so do some other viruses.